
USPH Stock Forecast & Price Target
USPH Analyst Ratings
Bulls say
US Physical Therapy Inc. has demonstrated a positive financial trajectory, highlighted by a sequential increase in commercial pricing of 2.2%. Additionally, revenue from the Industrial Injury Prevention (IIP) segment has seen robust growth, increasing by 22.2% overall and 18.4% when excluding merger and acquisition contributions. Moreover, the company has successfully improved its net rate for the recently acquired Metro business, rising from approximately $101 to $107.50, indicating strong operational performance and strategic positioning.
Bears say
US Physical Therapy has experienced a 0.6% decline in a key financial metric, dropping from $84.46 to $83.95 compared to the previous year. The company has faced persistent reimbursement cuts over the past five years, cumulatively impacting profitability by $20 million, which continues to weigh heavily on its financial outlook. Additionally, operating expenses related to rent and clinic costs have risen to 20.2% of revenue, surpassing initial estimates, further straining the company's financial performance.
This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.
USPH Analyst Forecast & Price Prediction
Start investing in USPH
Order type
Buy in
Order amount
Est. shares
0 shares